Enpro
Valuation each multiple against its own 5-year range
Vs. peers Specialty Industrial Machinery
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Enpro (NPO) | 5.35B | 86.01 | 3.29 | 0.50% |
| GE Vernova (GEV) | 185.10B | 18.36 | 16.26 | 0.25% |
| Eaton (ETN) | 120.95B | 31.01 | 5.77 | 1.39% |
| Parker Hannifin (PH) | 109.94B | 29.95 | 6.88 | 0.87% |
| Emerson Electric (EMR) | 82.80B | 31.51 | 3.99 | 1.47% |
| Illinois Tool Works (ITW) | 77.75B | 24.40 | 24.75 | 2.39% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 6.7% below Morningstar's fair value estimate.
Fair value
Enpro Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a minor 1% premium over our quantitative fair value estimate of $269.76 per share; however, this estimate should be taken with a pinch of salt due to its medium uncertainty rating.
The company's valuation metrics weaken our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. For example, the firm's book value yield of 29.8% ranks in the bottom 30% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are overvalued.
The firm's liquidity is an additional cause for concern. Excessive liquidity may suggest inefficient capital use or limited investment opportunities. The firm's median trading volume over the past 60 days, for example, falls in the top 50% compared with peers globally. High trading volumes could indicate a sharp change in business model or a new growth trajectory of the business. This characteristic further promotes our unfavorable price/fair value ratio.
Economic moat
The narrow moat rating for this company indicates investors can expect it to generate 10 years or more of excess returns on capital due to its respectable competitive advantages. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Enpro discussion 0 comments